• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Peloton Launches Second Generation Bike and Cheaper Version of Treadmill

Share:

September 16, 2020

The consumer fitness company is pitching its technology at various price points.

Peloton, the fitness company best known for its connected stationary bikes, has just added the second generation of its bike and a lower priced version of its connected treadmill.

Peloton Bike +, which is at a higher price point than the original, has additional software developed to guide users through yoga, stretching, meditation, and the more traditional spin classes.

The bike, which costs users just under $2,500, includes a connected touch screen, where users can choose a workout, as well as four speakers. Users can also opt into the “auto-follow” feature that can adjust bike resistance based on previously developed workout targets.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

The new treadmill, is cheaper than the previous version, which has now been renamed the Treadmill +, but also includes a touch screen with speakers. The company is pitching this new treadmill as a way to increase access to a larger base of customers.

WHY IT MATTERS

The coronavirus has create a ripe market for at-home workout equipment. With gyms closed for months on end, many are looking for alternatives. These new launches also offer more varied price points for Peloton devices. However, the lower priced bike is still $1,895, and the cheaper treadmill is $2,495.

“Our goal is to be the go-to at-home fitness solution for as many people as possible, and with these new product launches, we’ll be able to offer access to Peloton’s best-in-class fitness content at various price points, depending on what consumers are looking for, especially in a world where people are increasingly working out at home,” John Foley, Peloton’s CEO and cofounder, said in a statement.

THE LARGER TREND

Peloton went public a year ago offering just under $30 a share at opening. Today its per-share price has skyrocketed to close to $90. Since the start of the global pandemic the company’s revenue seems to be on the rise. In Q3 it reported a 66% YoY revenue increase.

Peloton has not been without its competitors. Earlier this year the company secured a settlement in a case against Flywheel, with the latter company admitting to patent infringement. As part of the deal Flywheel shut down its at-home classes.

Source: Mobihealth News

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • BroadReach Group Launches New Tool Aimed at Tackling Health Equity ChallengesBroadReach Group Launches New Tool Aimed at Tackling Health Equity Challenges
  • Why Clinical Trial Design Can Make or Break Your CompanyWhy Clinical Trial Design Can Make or Break Your Company
  • Amazon: AI And The $10 Trillion Healthcare OpportunityAmazon: AI And The $10 Trillion Healthcare Opportunity
  • APRINOIA Therapeutics Announces Mutual Termination of Business Combination Agreement with ROSS Acquisition Corp IIAPRINOIA Therapeutics Announces Mutual Termination of Business Combination Agreement with ROSS Acquisition Corp II
  • Cellular Biomedicine Group, Inc. Stockholders Approve MergerCellular Biomedicine Group, Inc. Stockholders Approve Merger
  • Infinity BiologiX Acquires Roylance PharmaInfinity BiologiX Acquires Roylance Pharma
  • Pharma playing catch-up as GDPR deadline nearsPharma playing catch-up as GDPR deadline nears
  • Cannmart announces asset purchase agreement with Buds2go.caCannmart announces asset purchase agreement with Buds2go.ca

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications